Mylan names 2 to board

  • February 11, 2013

CANONSBURG (AP) — Mylan Inc. said Monday that it has added two new members to its board of directors, expanding it to 13 members.

The pharmaceutical company’s board appointed Melina Higgins, a former partner at Goldman, Sachs & Co., and Rajiv Malik, Mylan’s president, to the board.

Higgins joined Goldman Sachs in 1989 and retired in 2010 after serving as a partner and in various leadership roles.

Malik has held important leadership positions at Mylan since January 2007, when the company acquired a controlling stake in Matrix Laboratories Ltd., now Mylan Laboratories Ltd. Malik was the CEO of the active pharmaceutical ingredients supplier.

Mylan Executive Chairman Robert J. Coury said the appointments deliver on the company’s objective of strengthening Mylan at all levels.

Mylan markets the EpiPen, an epinephrine auto-injector for treating severe allergic reactions. Pfizer Inc. makes EpiPen, and Mylan markets it in the U.S. Mylan also makes generic and specialty prescription drugs.


blog comments powered by Disqus

Mylan announces plans for low-cost AIDS treatment

Construction spending rises to highest level in 8 years

Factory activity drops in Nov.; first decline in 3 years

GM, Fiat Chrysler sales up in November, but Ford was flat

Cyber Monday sales still on top, but losing some luster

Fed moves to bar bailouts of failing firms

Pending homes sales edge up in October

PA Mug Co. owner moves to new studio space in Waynesburg

On the money: Making sure green home upgrades pay off

Dakota city that grew on fracking reaching out for more retail